Showing results (21-30 of 29) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
International Journal of Surgical Pathology|August 2, 2003
Distinct genetic and epigenetic changes in medullary breast cancerP Osin, Y-J Lu, J Stone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2Sunil R Lakhani, Marc J Van De Vijver, Jocelyne Jacquemier, et al.European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 5, 2005
Continued axillary sampling is unnecessary and provides no further information to sentinel node biopsy in staging breast cancerG P H Gui, D J Joubert, R Reichert, et al.BJS Open|April 9, 2019
Complete excision with narrow margins provides equivalent local control to wider excision in breast conservation for invasive cancerS S K Tang, F Rapisarda, A Nerurkar, et al.Oncogene|May 6, 1999
Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functionsP D Smith, S Crossland, G Parker, et al.British Journal of Cancer|July 17, 1999
BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital CollaboratorsS Gill, J Broni, S Jefferies, et al.Oncogene|October 31, 1998
p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumoursT Crook, L A Brooks, S Crossland, et al.British Journal of Cancer|March 1, 2002
E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasiaL A Brooks, A Sullivan, J O'Nions, et al.British Journal of Cancer|August 26, 2010
Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosisS M Edwards, D G R Evans, Q Hope, et al.Pageof 3